Difference between revisions of "Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8395)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Has Sectioning (P146): Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414), #quickstatements; #temporary_batch_1589488703697)
 
(3 intermediate revisions by the same user not shown)
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) / rank
 +
Normal rank

Latest revision as of 20:39, 14 May 2020

Publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection" in the journal Emerg Microbes Infect (2020); DOI: 10.1080/22221751.2020.1735265
Language Label Description Also known as
English
Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)
Publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection" in the journal Emerg Microbes Infect (2020); DOI: 10.1080/22221751.2020.1735265

    Statements

    0 references